IMAB
I-Mab - ADR

1,079
Loading...
Loading...
I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
32

Frequently Asked Questions

What is Market Cap of I-Mab - ADR?
What is the 52-week high for I-Mab - ADR?
What is the 52-week low for I-Mab - ADR?
What is I-Mab - ADR stock price today?
What was I-Mab - ADR stock price yesterday?
What is the PE ratio of I-Mab - ADR?
What is the Price-to-Book ratio of I-Mab - ADR?
What is the 50-day moving average of I-Mab - ADR?
How many employess does I-Mab - ADR has?

Latest IMAB News

View

Advertisement|Remove ads.

Advertisement|Remove ads.